TP53 and cancer: Furthermore, the p53 degradation causes a reduced glutaminolysis via the down-regulation of glutaminase 2 (GLS2), which, via the reduction in the α-ketoglutarate level, attenuates the function of the Krebs cycle, which is also one of the hallmarks of cancer.